Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
Knowing the symptoms and signs of a stroke and acting fast on time can save a person’s precious life.
On World Stroke Day, let us pledge to raise awareness of the serious nature of stroke and talk about ways in which we can reduce the burden of stroke.
Dr. Mansukh Mandaviya
Minister of Health and Family Welfare;
Chemicals and Fertilizers,
Govt. of India
Sponsor
Patient Safety Capsules
Health ministry constitutes 7-member panel to prepare 'National Drugs Database'
Mumbai, November 1, 2022: The Union ministry of health and family welfare has constituted a seven-member panel to prepare a comprehensive ‘National Drugs Database’ of drug formulations manufactured and marketed in the country. This will enhance regulatory oversight of medical products in the country to ensure their quality and bring uniformity to drug regulatory mechanisms across the country.
Indian healthcare advances with connected devices and AI-powered voice assistants
Bengaluru, October 29, 2022: Healthcare is undergoing a digital transformation with connected devices and AI-powered voice assistants. From interacting with medical professionals, use of telemedicine, to data access by physicians and streamlining administrative tasks has changed the face of healthcare.
Drug Laws & Policy Injections
NPPA extends time limit for submission of production, price data in IPDMS 2.0
New Delhi, October 28, 2022: The National Pharmaceutical Pricing Authority (NPPA) has extended the last date of filing statutory forms related to details of price list and quarterly returns prescribed under the Drugs (Prices Control) Order, 2013 for drugs and medical devices.
.
CDSCO directs states DCs to accept hard copy of application from medical devices traders for registration certificate
New Delhi, November 1, 2022: The Central Drugs Standard Control Organisation (CDSCO) has directed all the state drug controllers (DCs) to ac-cept the hard copy of the application to issue Registration Certificates to trade medical devices including in vitro diagnostic medical devices, which has been announced by the Union health ministry as an alternative to drugs sale license for these devices..
NPPA fixes price of 272 new drugs in the first six months of 2022-23New Delhi, November 1, 2022: The drug price regulator has fixed prices of 272 drugs and reviewed the price of one combination drug during the first six months of the current financial year, besides extending its price control measures on the Covid-19 related products, according to the Department of Pharmaceuticals (DoP)..
PCI allows institutions to restore admission intake to previous year levels
New Delhi, October 28, 2022: The Pharmacy Council of India (PCI) has decided to restore the student intake to the levels of the previous year, to those colleges which faced a reduction in admission intake for the year 2022-23 academic session.
QR code to curb spurious drugs circulation & its traceability through supply chain in Indian pharma
New Delhi, September 17, 2022: The Union health ministry on Tuesday added 34 new drugs to the National List of Essential Medicines (NLEM) 2022. The medicines have been categorised into 27 therapeutic categories with more anti-cancer, antibiotics and vaccines being added to the list, making them more affordable.
PSPC to appoint pharmacy inspectors to ensure presence of registered pharmacists in all pharmaciesChennai, October 29, 2022: After Kerala and Maharashtra, the Punjab State Pharmacy Council (PSPC) is planning to appoint pharmacy inspectors under Section 26 of the Pharmacy Act, 1948 to implement Section 42 to ensure presence of registered pharmacists in all pharmacies and to find out whether dispensing of medicines is carried out by unqualified people in any dispensing centre.
Pharma Injections
DoP rejects Ind-Swift’s review application on vitamin formulation Neurovit/Provita capsules
New Delhi, October 31, 2022: The Department of Pharmaceuticals (DoP) has rejected the review application of Ind-Swift Limited in connection to the National Pharmaceutical Pricing Authority (NPPA) fixing the retail prices of its vitamin formulation Neurovit/Provita capsules.
.
NPPA panel rejects Intas’ application for exemption from price fixing for Clozapine extended release capsules
NNEW DELHI, October 29, 2022: The expert panel of National Pharmaceutical Pricing Authority (NPPA) has once again rejected the application by Intas Pharmaceuticals Ltd for exemption from the provisions of Drug Price Control Order (DPCO) 2013, for various strengths for its antipsychotics formulation Clozapine extended release capsules.
DoP asks NPPA to reconsider retail price fixation on Abbott’s nutritional supplement Nervup Forte PlusNew Delhi, October 31, 2022: The Department of Pharmaceuticals (DoP) has sent the review application from Abbott Healthcare Pvt Ltd related to the retail price fixation of its nutritional supplement Nervup Forte Plus, back to the National Pharmaceutical Pricing Authority (NPPA) for reconsideration.
Care-Keralam to build Kerala Brand of Ayurveda Products for international markets
Chennai, October 31, 2022: Care Keralam, the Ayush cluster in Kerala, will shortly fine-tune its strategies to build ‘Kerala Brand of Ayurveda Products’ for international marketing and to increase the quantity of exports of traditional and herbal drugs from Kerala to global markets.
SII stopped Covishield production in Decemeber 2021: Poonawalla
PTI, 21October 2022: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, yesterday said the vaccine manufacturer stopped the production of the Covishield vaccine starting December 2021, and of the total stock available at that time, around 100 million doses had already got expired.
CPhI conferences announces 5th Annual Pharma Pre-Connect Congress IndiaNEW DELHI, 31October 2021: CPhI Conferences has announced the 5th Annual Pharma Pre-Connect Congress India 2022, to be held on 28th November in Greater Noida.
Drug Dopes
Avian flu outbreak: Central team holds discussions with Alappuzha Collector
Alappuzha, October 30, 2022: The high-level team of the Union Health Ministry to take stock of the avian influenza outbreak here on Sunday held discussions with the district Collector. 
India needs a three-pronged strategy to ensure regulatory accountabilityBengaluru, October 28, 2022 : India needs a three-pronged strategy to ensure regulatory accountability. First is the centralization of the drugs con-trol departments across the country. There is a need to create a cadre on similar lines of IAS (Indian Administrative Service), IPS (Indian Police Service) and IFS (Indian Forest Service) where the selection of officers is through UPSC (Union Public Service Commission).
NGOs working in health sector soon to meet in Delhi to urge Union govt to add more drugs under NLEMChennai, November 1, 2022: About 20 Non-Governmental Organizations (NGOs), working in the health sector in the country, are likely to meet in New Delhi soon to make a demand to the Union government to bring more number of costly medicines widely used in India under the ambit of the National List of Essential Medicines (NLEM) 2022.
MSF extends support to change in global cholera vaccine strategy amid unprecedented number of outbreaksMumbai, October 29, 2022: Due to the high number of countries currently experiencing cholera outbreaks and a shortage of oral cholera vaccine, Médecins Sans Frontières (MSF) has extended its support to the International Coordinating Group (ICG)’s decision to shift to a single dose of vaccine from the standard two-dose vaccination regimen administered during cholera outbreaks which will allow more people to be vaccinated.
India-made cough syrups may be tied to 66 deaths in Gambia: WHOOctober 5, 2022: The deaths of dozens of children in Gambia from kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday..
Scientists identify in humans neutralising antibody to Omicron variantsOctober 29, 2022: Researchers have identified in humans a pan-variant neutralising antibody, named S2X324, whose neu-tralizing potency was largely unaffected by any of the Omicron strains of the coronavirus, according to a study.
National Injections
Haryana regulator halts production at Maiden PharmaceuticalOctober 13, 2022: The Haryana government on Wednesday ordered Maiden Pharmaceuticals to stop production at the So-nipat plant after the central and state regulators detected irregularities and violations of good manufacturing processes at the plant.
Kolkata dengue cases alarming! Over 3,500 cases reported till October end
October 28, 2022: Dengue cases are continuously rising in West Bengal. The state recorded 596 new infections on Thursday. In this season, more than 40,000 dengue cases have been confirmed. Nearly 50 people have pe-rished due to dengue, also known as breakbone fever.
Digitization and advanced technology usher in transformation in cardiac care in India: experts
Mumbai, October 27, 2022: Technological developments, including telemedicine, wearable gadgets for early detection, and the application of robots and artificial intelligence in machine learning, have revolutionized cardiac care in India in the face of rising cases of cardiovascular disorders, including heart disease and stroke which cause 17.7 million deaths in India, said experts.
DoP amends operational guidelines for PLI scheme to change norms on claim submission
New Delhi, October 27, 2022: The Department of Pharmaceuticals (DoP) has amended the operational guidelines for the production linked incentive (PLI) scheme for pharmaceuticals once again, to allow the applicants to submit the claim of disbursement of incentive on a quarterly and half yearly basis, apart from the existing norm for submission of claim on an annual basis.
Indian pharma and healthcare sectors working to formalize workforce with third party payrollBengaluru, October 27, 2022: Indian pharma and healthcare sectors are working to formalise their workforce with third party payroll. This follows after employers citing their major concerns with an informal workforce. From an employer perspective, formalisation is needed because the primary challenge is to manage wages. There is also the issue of persistent skill gaps among the workforce. Yet another is frequent absenteeism that distorts the planned work schedule.
National capital records over 900 cases in October, tally rises to 1876
New Delhi, October 25, 2022: More than 900 cases of dengue have been reported in the national capital in October, taking the total infection tally of the vector-borne disease to 1,876 so far this year, according to a civic report issued on Tuesday. The city has also recorded 194 cases of malaria and 38 cases of chikungunya this year.
Global Injections
US FDA grants final approval to Zydus’s Micafungin for injectionOctober 26, 2022 : The United States Food and Drug Administration (FDA) has granted final approal to ZydusLifesciences for marketing Micafungin for injection, 50 mg/vial and 100 mg/vial, single-dose vials, ZydusLifesciences notified in a statement.
Indonesia considers prosecutions over cough syrup suspected of links to child deaths
October 26, 2022: Indonesia’s food and drugs agency recently said it may pursue criminal action against two pharma firms that made products linked to Acute Kidney Injury (AKI), amid a spike in cases and deaths among children this year.
AstraZeneca drug fails one main goal in study of chronic immune diseaseOctober 26, 2022: AstraZeneca said yesterday that its asthma drug Fasenra failed to meet one of the two main goals of a late-stage study assessing the treatment’s benefits in a chronic allergic condition that causes difficulty in swallowing.
Three pharma companies recall products in US
October 26, 2022: Dr Reddy’s Laboratories, Cipla and AurobindoPharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration (FDA).
Johnson and Johnson’s blood cancer therapy gets US FDA approvalOctober 25, 2022: The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s therapy for treating a type of multiple myeloma, the company said yesterday, giving another treatment option to patients with the incurable blood cancer.
EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate VaccineOctober 25, 2022 : The European Commission (EC) recently approved Merck’s expanded indication for Vaxneuvance (pneumococcal 15-valent conjugate vaccine) to include active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae (S pneumoniae) in infants, children and adolescents aged from six weeks to less than 18 years of age, a statement from Merck has notified.
PSAIIF PILL
ICMR and IISc team up for creation of gold standard medical data platform
Bengaluru, November 1, 2022: The Indian Council of Medical Research (ICMR) and the Indian Institute of Science (IISc), Bengaluru have inked a pact to collaborate on a national initiative towards the creation of high-quality medical data sets representing India’s diversity.
Indian pharma and healthcare sectors working to formalize workforce with third party payroll
Bengaluru, October 27, 2022: Indian pharma and healthcare sectors are working to formalise their workforce with third party payroll. This follows after employers citing their major concerns with an informal workforce. From an employer perspective, formalisation is needed because the primary challenge is to manage wages. There is also the issue of persistent skill gaps among the workforce. Yet another is frequent absenteeism that distorts the planned work schedule.
Frequently Asked Questions
How to manage arthritis and its related problems
October 23, 2022: Which age group is at risk for arthritis?
In India, women are more likely to develop arthritis than men in earlier years. As a result, the average age for the onset of knee problems among Indian women is 50 years, while it is 60 years for men.Read More>>>
SUBSCRIBER'S SYMPTOM
How gaming can positively influence mental health
October 22, 2022: Gaming has always been a popular pastime for many youngsters and adults alike. The advent of smart-phones, their affordability, and the pandemic itself have propelled gaming to new heights. The growth in its popularity has also led to gaming developing a not so positive reputation. However, there is a lack of data to substantiate claims and further research is required to better understand its impact.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
MsHansa Mehta, Professional
The Prescription has articles that make very good reading. Excellent presentation. Well done.
DrVivekVir Singh, MDThe Newsletter has extremely useful information for readers. Great reading, please continue.
MrPrem Atari, Pharma ExpertGood newsletter which brings an array of Pharma News for the avid Prescription newsletter. Keep up the good work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
